Swim stress exaggerates the hyperactive mesocortical dopamine system in a rodent model of autism

Brain Research

Volumn 1193, Issue , 2008, Pages 128-135

  Nakasato, Akane ^a,b   Nakatani, Yasushi ^a   Seki, Yoshinari ^a   Tsujino, Naohisa ^a   Umino, Masahiro ^b   Arita, Hideho ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Anxiety; Autism; Dopamine; Microdialysis; Rat; Stress

Indexed keywords

DOPAMINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; ESCAPE BEHAVIOR; FEMALE; FORCED SWIMMING TEST; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMOBILIZATION; IN VIVO STUDY; MENTAL STRESS; MICRODIALYSIS; NONHUMAN; PHYSICAL STRESS; PRIORITY JOURNAL; RAT; RODENT; STRESS; SWIMMING;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; AUTISTIC DISORDER; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOPAMINE; ESCAPE REACTION; FEMALE; FREEZING REACTION, CATALEPTIC; FRONTAL LOBE; MICRODIALYSIS; RAPHE NUCLEI; RATS; RATS, WISTAR; SEROTONIN; STRESS, PSYCHOLOGICAL; SWIMMING; VALPROIC ACID;

ANIMALIA; RATTUS; RODENTIA;

EID: 39149127555     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.11.043     Document Type: Article

References (29)

1. Adams J., Buelke-Sam J., Kimmel C.A., Nelson C.J., Reiter L.W., Sobotka T.J., Tilson H.A., and Nelson B.K. Collaborative Behavioral Teratology Study: protocol design and testing procedures. Neurobehav. Toxicol. Teratol. 7 (1985) 579-586
2. Anderson G.M., Freedman D.X., Cohen D.J., Volkmar F.R., Hoder E.L., McPhedran P., Minderaa R.B., Hansen C.R., and Young J.G. Whole blood serotonin in autistic and normal subjects. J. Child Psychol. Psychiatry 28 (1987) 885-900
3. Arndt T.L., Stodgell C.J., and Rodier P.M. The teratology of autism. Int. J. Dev. Neurosci. 23 (2005) 189-199
4. Bauman M., and Kemper T.L. Histoanatomic observations of the brain in early infantile autism. Neurology 35 (1985) 866-874
5. Dalla C., Antoniou K., Drossopoulou G., Xagoraris M., Kokras N., Sfikakis A., and Paoadopoulou-Daifoti Z. Chronic mild stress impact: are females more vulnerable?. Neuroscience 135 (2005) 703-714
6. Davis M. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 15 (1992) 353-375
7. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121 (1995) 66-72
8. Deutch A.Y., and Roth R.H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog. Brain Res. 85 (1990) 367-402
9. Gillberg C., Svennerholm L., and Hamilton-Hellberg C. Childhood psychosis and monoamine metabolites in spinal fluid. J. Autism Dev. Disord. 13 (1983) 383-396
10. Ingram J.L., Peckham S.M., Tisdale B., and Rodier P.M. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 22 (2000) 319-324
11. Kahne D., Tudorica A., Borella A., Shapiro L., Johnstone F., Huang W., and Whitaker-Azmitia P.M. Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiol. Behav. 75 (2002) 403-410
12. LeDoux J.E. Brain mechanisms of emotion and emotional learning. Curr. Opin. Neurobiol. 2 (1992) 191-197
13. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 8 (1997) 523-532
14. McCracken J.T., McGough J., Shah B., Cronin P., Hong D., Aman M.G., Arnold L.E., Lindsay R., Nash P., Hollway J., McDougle C.J., Posey D., Swiezy N., Kohn A., Scahill L., Martin A., Koenig K., Volkmar F., Carroll D., Lancor A., Tierney E., Ghuman J., Gonzalez N.M., Grados M., Vitiello B., Ritz L., Davies M., Robinson J., and McMahon D. Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral problems. N. Engl. J. Med. 347 (2002) 314-321
15. McDougle C.J., Scahill L., Aman M.G., McCracken J.T., Tierney E., Davies M., Arnold L.E., Posey D.J., Martin A., Ghuman J.K., Shah B., Chuang S.Z., Swiezy N.B., Gonzalez N.M., Hollway J., Koenig K., McGough J.J., Ritz L., and Vitiello B. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am. J. Psychiatry 162 (2005) 1142-1148
16. Miller M.T., Stromland K., Ventura L., Johansson M., Bandim J.M., and Gillberg C. Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Int. J. Dev. Neurosci. 23 (2005) 201-219
17. Miyazaki K., Narita N., and Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. Int. J. Dev. Neurosci. 23 (2005) 287-297
18. Morrow B.A., Elsworth J.D., Rasmusson A.M., and Roth R.H. The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience 92 (1999) 553-564
19. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., and Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr. Res. 52 (2002) 576-579
20. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. second ed. (1986), Academic Press
21. Pearson D.A., Loveland K.A., Lachar D., Lane D.M., Reddoch S.L., Mansour R., and Cleveland L.A. A comparison of behavioral and emotional functioning in children and adolescents with autistic disorder and PDD-NOS. Child Neuropsychol. 12 (2006) 321-333
22. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47 (1978) 379-391
23. Rodier P.M., Ingram J.L., Tisdale B., Nelson S., and Romano J. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 370 (1996) 247-261
24. Schneider T., and Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30 (2005) 80-89
25. Strömland K., Nordin V., Miller M., Akerström B., and Gillberg C. Autism in thalidomide embryopathy: a population study. Dev. Med. Child Neurol. 36 (1994) 351-356
26. Tsujino N., Nakatani Y., Seki Y., Nakasato A., Nakamura M., Sugawara M., and Arita H. Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism. Neurosci. Res. 57 (2007) 289-295
27. Vibert N., Serafin M., Crambes O., Vidal P.P., and Mühlethaler M. Dopaminergic agonists have both presynaptic and postsynaptic effects on the guinea-pig's medial vestibular nucleus neurons. Eur. J. Neurosci. 7 (1995) 555-562
28. Williams G., King J., Cunningham M., Stephan M., Kerr B., and Hersh J.H. Fetal valproate syndrome and autism: additional evidence of an association. Dev. Med. Child Neurol. 43 (2001) 202-206
29. Young J.G., Kavanagh M.E., Anderson G.M., Shaywitz B.A., and Cohen D.J. Clinical neurochemistry of autism and associated disorders. J. Autism Dev. Disord. 12 (1982) 147-165